Day for P4 Medicine
Thursday Feb 12th, 2026 at 9-17, Live event
Arvo Auditorium F115, Tampere University Kauppi campus, Arvo Ylpön katu 34, TRE
9 – 11.00 Co-innovation Session
12 – 15.40 Research Seminar
15.40 – 17 Networking Session
Coffee starting at 8.45
9.00 – 11.00 Co-innovation Session: funding & networking to develop solutions for P4 medicine. Chair: Ilona Raitakari, Senior Advisor, Business Tampere
Suitable funding methods for SME’s and Enterprises
9.00 – 9.20 Jari Ahola, Senior Business Advisor, Business Tampere: Active R&D funding instruments
Partnering for solution development for P4 Medicine
9.25 – 9.45 Prof. Juhana Frösen: Introducing TaU collaboration network: professors, research teams and core elements to create P4 Factory.
9.50 – 10.15 Prof. Kalle Kurppa: PRIMA P4 consortium – A new Finnish Academy project led by Pirha targeting individualized risk predictions and personalized prevention pathways.
10.20 – 10.35 Prof. Antti Vehkaoja: Collaboration opportunities for industrial partners in co-innovation projects in the area of P4 Medicine and digital twin platforms for risk assessment, predictive simulations and interventions.
10.40 – 11.00 Call to action: how can industry partners engage in the projects?
11.00 -12.00 Lunch (self-paid)
12 – 15.40 Research seminar on P4 Medicine
Arvo Auditorium F115, Tampere University Kauppi campus, Arvo Ylpön katu 34, Tampere
12 – 12.10 Opening: Dean Seppo Parkkila, Faculty of Medicine and Health Technology (MET), Tampere University (TAU).
Chair: Juulia Jylhävä, Group leader, Senior Research Fellow, MET, TAU, and Associate Prof., Faculty of Medicine, University of Oulu.
12.10 – 12.20 Kati Kristiansson, Director of Research and Development, The Wellbeing Services County of Pirkanmaa: P4 medicine: collaboration with the Wellbeing Services County of Pirkanmaa.
12.25 – 12.35 Sanna Siltanen, Director, Finnish Clinical Biobank Tampere: Biobanks and P4 medicine.
12.40 – 12.50 Arja Halkoaho, Prof. of Practice in P4 Medicine, TAU and TAMK: P4 Medicine Challenges Education: Are We Ready?
Talks on research projects related to P4 medicine and seed funded by the MET faculty
12.55 – 13.05 Prof. Katri Lindfors, MET, TAU: Towards personalized medicine in celiac disease – a genetic perspective.
13.10 – 13.20 Veera Räkköläinen, MSc, MET, TAU: P4 Medicine for Celiac and Refractory Celiac Disease: Molecular Mechanisms guiding Precision Immunomodulatory Therapy – CELIAC-IMT.
13.25 – 13.35 Amir-Babak Sioofy-Khojine, Senior Scientist, MET, TAU: From Predictive Lipid Biomarkers to Participatory Therapies: A P4 Framework for Chronic enterovirus Infection.
13.40 – 14.10 Break and coffee
14.10 – 14.20 Xin Lai, Assistant Prof., MET, TAU: Identification of functional microRNA-gene interactions for regulating atorvastatin treatment in prostate cancer.
14.25 – 14.35 Prof. Kalle Kurppa, MET, TAU: Personalized Maternity Care utilizing Digital solutions for Multidimensional Childhood Obesity Prevention and Improving Family Wellbeing.
14.40 – 14.50 Prof. Heikki Hyöty, MET, TAU: Creation of a unified data and sample resource to strengthen P4 medicine in MET.
14.55 – 15.05 Prof. Olli Yli-Harja, MET, TAU: Agile modeling tool for health-economics in type 1 diabetes.
15.10 – 15.20 Juulia Jylhävä, Senior Research Fellow, Tampere Institute for Advanced Study and MET, TAU: AI-driven frailty assessment through an electronic frailty index (eFI): toward predictive, preventive and person-centered healthcare.
15.25 – 15.35 Prof. Mark van Gils, MET, TAU: PHORMA – Participatory Health Offerings and a RoadMap towards Action.
15.40 Research seminar ends
15.40 – 17.00 Networking Session. Organiser: Business Tampere. Juvenes cafeteria, Arvo building, 1st floor, Kauppi campus.